Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Astrocytes | 6 | 2024 | 1338 | 1.810 |
Why?
|
Alzheimer Disease | 12 | 2024 | 8547 | 1.660 |
Why?
|
Calcium | 11 | 2024 | 5725 | 1.030 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18137 | 0.920 |
Why?
|
Mice, Transgenic | 8 | 2024 | 9530 | 0.860 |
Why?
|
Amyloid beta-Peptides | 7 | 2024 | 3832 | 0.780 |
Why?
|
Coculture Techniques | 1 | 2024 | 1342 | 0.680 |
Why?
|
Neuroprotective Agents | 2 | 2024 | 961 | 0.650 |
Why?
|
Amyloid beta-Protein Precursor | 5 | 2024 | 1110 | 0.610 |
Why?
|
Memory, Short-Term | 1 | 2024 | 978 | 0.580 |
Why?
|
Motor Neurons | 3 | 2013 | 865 | 0.570 |
Why?
|
Memory Disorders | 1 | 2024 | 1197 | 0.550 |
Why?
|
Plaque, Amyloid | 5 | 2022 | 758 | 0.540 |
Why?
|
Amyloidosis | 1 | 2022 | 817 | 0.520 |
Why?
|
Homeostasis | 2 | 2017 | 3306 | 0.510 |
Why?
|
Amyloid | 2 | 2019 | 842 | 0.500 |
Why?
|
Systems Biology | 1 | 2019 | 482 | 0.500 |
Why?
|
Neurons | 6 | 2024 | 9426 | 0.490 |
Why?
|
Neurosciences | 1 | 2019 | 353 | 0.470 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1084 | 0.450 |
Why?
|
Rhodopsin | 2 | 2013 | 203 | 0.440 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.410 |
Why?
|
Aging | 3 | 2024 | 8651 | 0.330 |
Why?
|
Mice | 14 | 2024 | 81208 | 0.320 |
Why?
|
Action Potentials | 2 | 2013 | 1816 | 0.320 |
Why?
|
Animals | 21 | 2024 | 167963 | 0.300 |
Why?
|
Spinal Cord | 2 | 2021 | 1817 | 0.300 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22023 | 0.270 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 2 | 2019 | 266 | 0.270 |
Why?
|
Receptors, GABA-A | 1 | 2010 | 621 | 0.260 |
Why?
|
Axons | 1 | 2013 | 1673 | 0.250 |
Why?
|
Synaptic Transmission | 3 | 2019 | 1171 | 0.220 |
Why?
|
Brain | 6 | 2023 | 26951 | 0.200 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.200 |
Why?
|
Immunotherapy | 1 | 2016 | 4642 | 0.180 |
Why?
|
Sleep Stages | 1 | 2024 | 691 | 0.180 |
Why?
|
Calcium, Dietary | 1 | 2023 | 531 | 0.180 |
Why?
|
Chick Embryo | 2 | 2013 | 981 | 0.170 |
Why?
|
Down-Regulation | 2 | 2017 | 2913 | 0.170 |
Why?
|
Calcium Signaling | 1 | 2023 | 732 | 0.160 |
Why?
|
Interneurons | 1 | 2022 | 591 | 0.150 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4407 | 0.150 |
Why?
|
Nootropic Agents | 1 | 2018 | 157 | 0.140 |
Why?
|
Presenilin-1 | 2 | 2018 | 660 | 0.130 |
Why?
|
Brain Chemistry | 1 | 2019 | 959 | 0.130 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 663 | 0.120 |
Why?
|
Microglia | 1 | 2023 | 1351 | 0.120 |
Why?
|
Nitric Oxide | 1 | 2024 | 2141 | 0.120 |
Why?
|
Disease Progression | 2 | 2023 | 13502 | 0.120 |
Why?
|
Spinal Nerves | 1 | 2013 | 91 | 0.110 |
Why?
|
Avian Proteins | 1 | 2013 | 80 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2019 | 818 | 0.100 |
Why?
|
Quadriceps Muscle | 1 | 2013 | 154 | 0.100 |
Why?
|
Periodicity | 1 | 2013 | 348 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2019 | 8950 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 893 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2024 | 5125 | 0.090 |
Why?
|
Picrotoxin | 1 | 2010 | 62 | 0.090 |
Why?
|
Sleep | 2 | 2023 | 4751 | 0.090 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1132 | 0.090 |
Why?
|
GABA Antagonists | 1 | 2010 | 120 | 0.090 |
Why?
|
Cells, Cultured | 2 | 2024 | 18957 | 0.090 |
Why?
|
Synaptic Vesicles | 1 | 2011 | 190 | 0.080 |
Why?
|
Exocytosis | 1 | 2011 | 319 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1974 | 0.080 |
Why?
|
Muscle Contraction | 1 | 2013 | 1201 | 0.080 |
Why?
|
Electromyography | 1 | 2013 | 1388 | 0.080 |
Why?
|
Cerebral Cortex | 1 | 2024 | 5761 | 0.080 |
Why?
|
Neuromuscular Junction | 1 | 2011 | 406 | 0.080 |
Why?
|
Light | 1 | 2013 | 1344 | 0.070 |
Why?
|
Endocytosis | 1 | 2011 | 959 | 0.070 |
Why?
|
Models, Neurological | 1 | 2013 | 1758 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6238 | 0.060 |
Why?
|
Nerve Net | 1 | 2016 | 2261 | 0.060 |
Why?
|
Humans | 10 | 2024 | 760621 | 0.050 |
Why?
|
Infrared Rays | 1 | 2024 | 246 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9185 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2024 | 704 | 0.050 |
Why?
|
Signal Transduction | 1 | 2024 | 23376 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11071 | 0.040 |
Why?
|
Male | 4 | 2024 | 359744 | 0.040 |
Why?
|
Neuroglia | 1 | 2023 | 944 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2024 | 1501 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2022 | 1967 | 0.030 |
Why?
|
Phytotherapy | 1 | 2018 | 295 | 0.030 |
Why?
|
Wakefulness | 1 | 2022 | 1255 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2017 | 419 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2733 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2394 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 924 | 0.030 |
Why?
|
Brain Diseases | 1 | 2021 | 1540 | 0.020 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2011 | 100 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4035 | 0.020 |
Why?
|
Brain Injuries | 1 | 2021 | 2044 | 0.020 |
Why?
|
Protein Conformation | 1 | 2017 | 3969 | 0.020 |
Why?
|
Learning | 1 | 2018 | 1739 | 0.020 |
Why?
|
Electrophysiology | 1 | 2011 | 1265 | 0.020 |
Why?
|
Electroencephalography | 1 | 2022 | 6189 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2011 | 1199 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8313 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10827 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14495 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22053 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58995 | 0.010 |
Why?
|
Female | 2 | 2018 | 391270 | 0.010 |
Why?
|
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_